CD8A and neoplasm: The addition of immune checkpoint inhibitors to activate PD-1+ CD8+ cells synergistically boosted anti-tumor activity [191], and local radiotherapy also synergistically promoted the cancer vaccine anti-tumor activity by enhancing DC sensing of tumor antigens [20, 185, 186].